Genyou Corporation: the products sold by the company in the US do not fall under the scope of the new US pharmaceutical tariffs.

According to the Securities Department of Jianyou Group, the company's main products sold in the United States are heparin products and other generic drugs. These products are either shipped directly to the United States or sold through Jianyou in Hong Kong. Currently, there are no tariffs on the export of the company's heparin-related products to the United States. The company does not sell innovative drug products in the United States, so the company's revenue in the US should not be affected. The White House in the United States announced on the 2nd that President Trump signed a document on the same day to impose a 100% tariff on imported patented drugs and pharmaceutical ingredients.